These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 3092967)

  • 1. Campylobacter pyloridis and associated gastritis: investigator blind, placebo controlled trial of bismuth salicylate and erythromycin ethylsuccinate.
    McNulty CA; Gearty JC; Crump B; Davis M; Donovan IA; Melikian V; Lister DM; Wise R
    Br Med J (Clin Res Ed); 1986 Sep; 293(6548):645-9. PubMed ID: 3092967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bismuth subsalicylate in the treatment of gastritis due to Campylobacter pylori.
    McNulty CA
    Rev Infect Dis; 1990; 12 Suppl 1():S94-8. PubMed ID: 2406863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The treatment of Campylobacter-associated gastritis.
    McNulty CA
    Am J Gastroenterol; 1987 Mar; 82(3):245-7. PubMed ID: 3493685
    [No Abstract]   [Full Text] [Related]  

  • 4. Campylobacter pyloridis and gastritis.
    Marshall BJ
    J Infect Dis; 1986 Apr; 153(4):650-7. PubMed ID: 3512736
    [No Abstract]   [Full Text] [Related]  

  • 5. Rapid urease test in the management of Campylobacter pyloridis-associated gastritis.
    Marshall BJ; Warren JR; Francis GJ; Langton SR; Goodwin CS; Blincow ED
    Am J Gastroenterol; 1987 Mar; 82(3):200-10. PubMed ID: 3548326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preliminary study on the microbiology of Campylobacter pyloridis and gastric histopathology.
    Ren J; Pan BR; Li MF; Lu P; Yan PS; Miao JY; Dong Y; Luo WH
    Keio J Med; 1990 Jun; 39(2):112-6. PubMed ID: 2214500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Bismuth subsalicylate treatment in chronic Campylobacter pylori-associated erosive gastritis].
    Malfertheiner P; Stanescu A; Baczako K; Vanek E; Bode G; Ditschuneit H
    Dtsch Med Wochenschr; 1988 Jun; 113(23):923-9. PubMed ID: 3378501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of bismuth subsalicylate on the histologic gastritis seen with Campylobacter pylori: a placebo-controlled, randomized study.
    Lanza FL; Skoglund ML; Rack MF; Yardley JH
    Am J Gastroenterol; 1989 Sep; 84(9):1060-4. PubMed ID: 2773899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A placebo controlled trial of bismuth salicylate in Helicobacter pylori associated gastritis.
    Kazi JI; Jafarey NA; Alam SM; Zuberi SJ; Kazi AM; Qureshi H; Ahmed W
    J Pak Med Assoc; 1990 Jul; 40(7):154-6. PubMed ID: 2125658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Campylobacter pyloridis-associated chronic active antral gastritis. A prospective study of its prevalence and the effects of antibacterial and antiulcer treatment.
    Rauws EA; Langenberg W; Houthoff HJ; Zanen HC; Tytgat GN
    Gastroenterology; 1988 Jan; 94(1):33-40. PubMed ID: 3335295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Campylobacter pyloridis, gastritis, and peptic ulceration.
    Goodwin CS; Armstrong JA; Marshall BJ
    J Clin Pathol; 1986 Apr; 39(4):353-65. PubMed ID: 3517070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Campylobacter pyloridis in peptic ulcer disease. I. Gastric and duodenal infection caused by C. pyloridis: histopathologic and microbiologic findings.
    Andersen LP; Holck S; Povlsen CO; Elsborg L; Justesen T
    Scand J Gastroenterol; 1987 Mar; 22(2):219-24. PubMed ID: 3576129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical significance, epidemiology and laboratory diagnosis of Campylobacter pyloridis].
    Kasper G; Dickgiesser N
    Immun Infekt; 1986 Apr; 14(2):58-62. PubMed ID: 3710514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenicity of Campylobacter pylori--a causative factor in gastritis?
    McNulty CA
    Scand J Gastroenterol Suppl; 1989; 160():3-6. PubMed ID: 2683021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nodular gastritis and Helicobacter pylori.
    Bujanover Y; Konikoff F; Baratz M
    J Pediatr Gastroenterol Nutr; 1990 Jul; 11(1):41-4. PubMed ID: 2388131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ingestion of Campylobacter pyloridis causes gastritis and raised fasting gastric pH.
    Morris A; Nicholson G
    Am J Gastroenterol; 1987 Mar; 82(3):192-9. PubMed ID: 3826027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of Campylobacter pylori-associated antral gastritis in children with bismuth subsalicylate and ampicillin.
    Drumm B; Sherman P; Chiasson D; Karmali M; Cutz E
    J Pediatr; 1988 Nov; 113(5):908-12. PubMed ID: 3183851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Campylobacter pylori-associated gastritis: a double-blind placebo-controlled trial with amoxycillin.
    Glupczynski Y; Burette A; Labbe M; Deprez C; De Reuck M; Deltenre M
    Am J Gastroenterol; 1988 Apr; 83(4):365-72. PubMed ID: 3279757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enzyme-linked immunosorbent assay for Campylobacter pyloridis: correlation with presence of C. pyloridis in the gastric mucosa.
    Goodwin CS; Blincow E; Peterson G; Sanderson C; Cheng W; Marshall B; Warren JR; McCulloch R
    J Infect Dis; 1987 Mar; 155(3):488-94. PubMed ID: 3805774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Campylobacter pyloridis in the upper gastrointestinal tract: a Brazilian study.
    Coelho LG; Das SS; Karim QN; Walker MM; Queiroz DM; Mendes EN; Lima Júnior GF; de Oliveira CA; Baron JH; Castro Lde P
    Arq Gastroenterol; 1987; 24(1):5-9. PubMed ID: 3450271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.